Skip to main content

AbCellera Biologics Inc.

ABCL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001703057

In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.

Politicians who traded ABCL

No member of Congress has reported a trade in AbCellera Biologics Inc. shares or options since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.